Novel Neuromuscular Protection to CounterACT Organophosphorus (OP) Poisoning
对抗有机磷 (OP) 中毒的新型神经肌肉保护
基本信息
- 批准号:8337703
- 负责人:
- 金额:$ 40.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholinesteraseAcuteAddressAnimal ModelAntidotesArchitectureAtropineBenzodiazepinesChemical WarfareDataDevelopmentDimethoateEffectivenessFailureHourHumanIntensive CareInvestigationLaboratoriesMechanical ventilationMethodsMilitary PersonnelMiniature SwineModelingMorbidity - disease rateMuscarinicsMuscle WeaknessNIH Program AnnouncementsNeurologicNeuromuscular JunctionNicotinic ReceptorsOximesParathionPatientsPesticidesPhysiologicalPhysiologyPoisoningPopulationPublic HealthReceptor ActivationResearchResearch ActivityRespiratory FailureResuscitationSeizuresToxic effectToxinUnited States National Institutes of Healthcholinergicclinical applicationclinically relevantevidence basehemodynamicsimprovedinnovationmortalitynerve agentneuromuscularneuromuscular transmissionnovelpesticide poisoningrespiratorytherapeutic target
项目摘要
DESCRIPTION (provided by applicant): The acute toxicity of OPs is primarily due to inhibition of acetylcholinesterase (AChE). Current therapy for OP poisoning requires resuscitation with the use of atropine, followed by administration of oximes to reactivate AChE, and benzodiazepines to mitigate neurological complications. However, these antidotes have limited effectiveness and between 10 and 40% of patients, depending on the responsible OP, still die even with intensive care support. Furthermore, acute failure of neuromuscular transmission leads to respiratory failure and prolonged weakness. This failure of the neuromuscular junction (NMJ) has recently been shown to occur within hours after severe poisoning. The purpose of this application is to determine the physiologic and electromyographic efficacy of the nicotinic receptor antagonist rocuronium in preserving NMJ function and NMJ architecture in novel minipig models of dimethoate and parathion poisoning. Our central hypothesis is that pharmacologic targeting of the NMJ with rocuronium will improve NMJ function and NMJ architecture in minipig models OP poisoning. Data generated from these studies will enable the development of further research activities directed towards therapeutic targeting of the NMJ. Lastly, while these studies are critically applicable to chemical warfare and mass casualty situations, they are also applicable to
isolated cases of severe OP poisoning that occur every day in the U.S. and abroad.
描述(申请人提供):有机磷农药的急性毒性主要是由于对乙酰胆碱酯酶(AChE)的抑制。目前对OP中毒的治疗需要使用阿托品进行复苏,然后使用肟类药物重新激活AChE,并使用苯二氮卓类药物来减轻神经系统并发症。然而,这些解毒剂的效果有限,根据负责的OP,10%至40%的患者即使在重症监护支持下仍会死亡。此外,神经肌肉传递的急性故障会导致呼吸衰竭和长期虚弱。这种神经肌肉接头(NMJ)的失效最近被证明发生在严重中毒后的几个小时内。本研究旨在探讨烟碱受体拮抗剂罗库溴铵在氧乐果和对硫磷中毒小型猪模型中保留NMJ功能和NMJ构筑的生理学和肌电效应。我们的中心假设是,在小型猪OP中毒模型中,以罗库溴铵为靶点的NMJ将改善NMJ功能和NMJ结构。这些研究产生的数据将使针对NMJ治疗靶点的进一步研究活动得以开展。最后,虽然这些研究关键地适用于化学战和大规模伤亡情况,但它们也适用于
在美国和国外每天都会发生严重的OP中毒的孤立案例。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN B BIRD其他文献
STEVEN B BIRD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN B BIRD', 18)}}的其他基金
Pharmacotherapy to counterACT parathion-induced NMJ dysfunction
对抗 ACT 对硫磷引起的 NMJ 功能障碍的药物治疗
- 批准号:
8735218 - 财政年份:2013
- 资助金额:
$ 40.89万 - 项目类别:
Pharmacotherapy to counterACT parathion-induced NMJ dysfunction
对抗 ACT 对硫磷引起的 NMJ 功能障碍的药物治疗
- 批准号:
8545988 - 财政年份:2013
- 资助金额:
$ 40.89万 - 项目类别:
USE OF AN ORGANOPHOSPHORUS (OP) HYDROLASE FOR ACUTE OP TOXICITY
使用有机磷 (OP) 水解酶治疗急性 OP 毒性
- 批准号:
8357959 - 财政年份:2011
- 资助金额:
$ 40.89万 - 项目类别:
Novel Neuromuscular Protection to CounterACT Organophosphorus (OP) Poisoning
对抗有机磷 (OP) 中毒的新型神经肌肉保护
- 批准号:
8216503 - 财政年份:2011
- 资助金额:
$ 40.89万 - 项目类别:
USE OF AN ORGANOPHOSPHORUS (OP) HYDROLASE FOR ACUTE OP TOXICITY
使用有机磷 (OP) 水解酶治疗急性 OP 毒性
- 批准号:
8172874 - 财政年份:2010
- 资助金额:
$ 40.89万 - 项目类别:
USE OF AN ORGANOPHOSPHORUS (OP) HYDROLASE FOR ACUTE OP TOXICITY
使用有机磷 (OP) 水解酶治疗急性 OP 毒性
- 批准号:
7958389 - 财政年份:2009
- 资助金额:
$ 40.89万 - 项目类别:
Use of an Organophosphorus (OP) Hydrolase for Acute OP Poisoning
使用有机磷 (OP) 水解酶治疗急性 OP 中毒
- 批准号:
7489907 - 财政年份:2007
- 资助金额:
$ 40.89万 - 项目类别:
Use of an Organophosphorus (OP) Hydrolase for Acute OP Poisoning
使用有机磷 (OP) 水解酶治疗急性 OP 中毒
- 批准号:
7313289 - 财政年份:2007
- 资助金额:
$ 40.89万 - 项目类别:
fMRI Assessment of Organophosphate Neurotoxicity
有机磷神经毒性的功能磁共振成像评估
- 批准号:
6991212 - 财政年份:2004
- 资助金额:
$ 40.89万 - 项目类别:
fMRI Assessment of Organophosphate Neurotoxicity
有机磷神经毒性的功能磁共振成像评估
- 批准号:
6870691 - 财政年份:2004
- 资助金额:
$ 40.89万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 40.89万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 40.89万 - 项目类别:
Operating Grants